文献速递关节外科

蜂毒肽通过抑制NF-kB通路并调节核因子κB受体活化因子配体/骨保护素比值治疗大鼠假体周围骨溶解

Melittin Treats Periprosthetic Osteolysis in a Rat Model by Inhibiting the NF-kB Pathway and Regulating the Ratio of Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin.
PubMed 文献 · J Arthroplasty · 2024-02-08

该研究将20只雄性Sprague-Dawley大鼠随机分为5组(假手术组、模型组及蜂毒肽0.2、0.4、0.6 mg/kg三组),植入钛棒并暴露于聚乙烯颗粒,观察蜂毒肽对假体周围骨溶解的影响。结果显示蜂毒肽组血清磷、钙磷乘积、骨保护素、PINP、PINP/CTX-I及OPG/RANKL比值显著升高(P < .05),假体周围骨缺损减少,IKKα和P65表达下降,破骨细胞及炎症细胞浸润减少。结论认为蜂毒肽可抑制NF-kB通路、降低RANKL/OPG影响,从而延缓破骨细胞活性并减轻假体周围骨溶解。

要点

  • 蜂毒肽组血清磷、钙磷乘积、骨保护素、PINP、PINP/CTX-I及OPG/RANKL比值较模型组显著升高(P < .05)。
  • 蜂毒肽组显微CT显示假体周围骨缺损量减少,免疫荧光显示IKKα和P65表达下降、骨保护素表达呈上升趋势。
  • HE与抗酒石酸酸性磷酸酶染色显示蜂毒肽组骨吸收陷窝内破骨细胞及炎症细胞浸润减少。

核心结论

  • 研究表明蜂毒肽在大鼠模型中能抑制NF-kB通路并降低RANKL/OPG的影响,从而延缓破骨细胞活性、减轻假体周围骨溶解。

研究设计与样本

  • 共20只雄性Sprague-Dawley大鼠(10月龄,无特定病原体级,350 g ± 20 g)随机分为5组:假手术组、模型组、蜂毒肽浓度1组(0.2 mg/kg)、浓度2组(0.4 mg/kg)、浓度3组(0.6 mg/kg)。
  • 所有大鼠植入TA2高纯度钛棒,用钻头沿股骨长轴在髁间窝制作骨道;模型组和实验组暴露于聚乙烯颗粒,假手术组未接受任何颗粒。

主要发现

  • 蜂毒肽组血清磷、钙磷乘积、骨保护素、PINP、PINP/CTX-I及OPG/RANKL水平显著升高(P < .05)。
  • 实验组显微计算机断层扫描显示假体周围骨缺损量减少。
  • 免疫荧光分析显示IKKα和P65表达下降,骨保护素表达呈上升趋势。
  • 苏木精-伊红染色和抗酒石酸酸性磷酸酶染色均显示骨吸收陷窝内破骨细胞及炎症细胞浸润减少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aseptic loosening around the prosthesis is a common cause of failure in total joint arthroplasty. Polyethylene wear particles trigger the release of inflammatory factors by macrophages. Key mediators involved in osteoclastogenesis include interleukin-6, tumor necrosis factor-α, receptor activator of nuclear factor kappa B (RANK), RANK ligand (RANKL), and bone protection hormone (Osteoprotegerin [OPG]). The purpose of our experiment was to see whether melittin can slow down the release of inflammatory mediators through the NF-kB pathway, regulate the RANKL/OPG ratio, reduce osteoclast formation, and delay the onset of arthritis in rats. METHODS: A total of 20 male Sprague-Dawley rats (10 months, Specific Pathogen Free, 350 g ± 20 g) were randomly divided into 5 groups: sham group, model group, melittin concentration 1 group (0.2 mg/kg), concentration 2 group (0.4 mg/kg), and concentration 3 group (0.6 mg/kg). All rats were implanted with TA2 high-purity titanium rods. A drill was used to create a bone canal along the long axis of the femur in the intercondylar notch. The model group and experimental groups were exposed to polyethylene particles, while the sham group did not receive any particles. RESULTS: The melittin group exhibited significantly increased serum levels of serum P, calcium-phosphorus product, OPG, PINP, PINP/CTX-I, and OPG/RANKKL (P < .05). In the experimental group, micro computed tomography scanning results revealed a decrease in the amount of bone defect around the prosthesis. Immunofluorescence analysis demonstrated a decrease in the expression of IKKα and P65, while the expression of OPG showed an upward trend. Both Hematoxylin-Eosin and Tartrate-Resistant Acid Phosphatase staining revealed less osteoclast and inflammatory cell infiltration in bone resorption pits. CONCLUSIONS: Our study demonstrates that melittin has the ability to inhibit the NF-kB pathway in a rat model, and reduce the impact of RANKL/OPG, thereby delaying osteoclast activity and alleviating periprosthetic osteolysis.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Niu J, Bi F, Tian Q, et al. Melittin Treats Periprosthetic Osteolysis in a Rat Model by Inhibiting the NF-kB Pathway and Regulating the Ratio of Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin. J Arthroplasty. 2024. PMID: 38336308. doi:10.1016/j.arth.2024.01.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。